Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Waterdrop Inc. Announces First Quarter 2021 Unaudited Financial Results 2021-06-17 15:05
InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma 2021-06-17 11:31
Spark™ Aligners Receive FDA Clearance For Orthodontic Treatment Of Kids, Giving Parents A New Option With Significant Treatment Advantages Over The Leading Competitor 2021-06-16 21:05
Spark Aligners Does It Again With Market Leading Innovation And New FDA Approval To Give Doctors Greater Control And Flexibility 2021-06-16 20:45
SMIC Liver Transplant Program's Ninth Donation Raised Over 33 Million Yuan 2021-06-16 17:48
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment 2021-06-16 13:08
Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci 2021-06-16 10:14
 Smith+Nephew launches Real Intelligence and CORI™ Surgical System, next generation robotics platform, in Australia and New Zealand 2021-06-16 06:00
VNTC confirms Dong-A ST its sole distributor of scoliosis brace Spinamic in South Korea 2021-06-16 00:00
Frontera Therapeutics Starts GMP Manufacturing Facility Construction 2021-06-15 23:32
BIO Digital Taiwan Day will be held on June 22 2021-06-15 23:00
Kazia Enters Clinical Collaboration With Cornell University for Phase II Clinical Study Using Paxalisib in Combination With Ketogenic Diet for Glioblastoma 2021-06-15 22:00
The U.S. FDA Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2021-06-15 08:46
Happiness Biotech Signed Agreement To Distribute Volkswagen Electric Vehicles 2021-06-14 20:00
Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab 2021-06-14 15:00
Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis 2021-06-14 06:00
ImmVira completed the first dosing for Phase II of MVR-T3011 (intratumoral injection) in the U.S. and China 2021-06-12 11:16
United Imaging Splashes Out at SNMMI 2021 With Clinical and Preclinical Technologies, Total-body AI, and Award-Winning Business Programs 2021-06-11 20:10
Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou 2021-06-11 18:11
Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or refractory follicular lymphoma at the European Hematology Association 2021 Congress 2021-06-11 13:05